Natera (NTRA) Insider Rowan Chapman Buys 1,674 Shares
Rowan Chapman purchased 1,674 shares of Natera, Inc. on June 26, 2026.
Reviewed by automated data checks against the source filing. How we make and check alerts
Rowan Chapman bought 1,674 shares of Natera, Inc. ($NTRA) on June 26, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $NTRA is up 8.4% after 1 week, down 1.5% after 1 month and up 50.2% to date (from the $261.91 close on Jun 26, 2026).
NTRA
Natera, Inc.
Key Points
- Rowan Chapman bought 1,674 shares of Natera, Inc. on June 26, 2026, at a price of $267.05 each.
- Other insiders also bought shares on the same day, including Thomas Lynch Jr. who acquired 1,905 shares.
- Analysts maintain a strong outlook for Natera, with a consensus rating of 'strong buy' and a mean price target of $348.02.
Get $NTRA trade alerts by text
We text you when insiders, Congress or big funds trade $NTRA. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Natera, Inc. alert may contain errors. Disclosures
Insider Buying and Selling at Natera, Inc.
Rowan Chapman bought 1,674 shares of Natera, Inc. (NTRA) on June 26, 2026, at a price of $267.05 each. This purchase reflects a growing interest from insiders in the company, which has seen several others making similar moves on the same day.
Other Insiders Join In
On the same day, several other insiders also bought shares of Natera. Thomas Lynch Jr. acquired 1,905 shares, while Roelof Botha purchased 1,691 shares. Eric Rubin bought 75 shares, and Roy Baynes acquired 1,646 shares. This collective buying activity could indicate a shared confidence among company insiders in Natera's future prospects.
Analysts Set New Price Targets
Analysts have a positive outlook on Natera, with a consensus rating of 'strong buy' and a mean price target of $348.02. Recent reports show that JP Morgan has maintained an Overweight rating with a target increase to $460 on October 14, 2026. Other firms, like Morgan Stanley and TD Cowen, have also kept their Overweight and Buy ratings, respectively, with similar target price increases.
Stock Performance Context
Natera's stock has been fluctuating, with a previous close of $369.39. The stock has a 52-week range between $157.43 and $373.07, suggesting it is currently trading well below its high. This context makes the recent insider purchases noteworthy, as they come during a period of volatility.
What Natera, Inc. Does
Natera, Inc., based in Austin, Texas, focuses on molecular testing services. It offers various tests for cancer detection, prenatal screening, and other genetic assessments. The recent insider activity may reflect a belief in the company's ongoing projects and growth potential in the diagnostics sector.
What’s Next for Natera
Looking ahead, Natera is set to announce its next earnings on November 5, 2026. As a reminder, the recent insider transactions are based on reports filed under the STOCK Act and reflect positions as of their transaction dates, which may not represent current holdings.
Related Filing Alerts
Source: Rowan Chapman's Form 4 filing on $NTRA (Jun 26, 2026). Find the original filing: NTRA Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts